Healthcare provider profile · identity verified

Eugene Lao

Family Practice · MILILANI, HI · NPI 1811303605

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	768	233
Amlodipine Besylate	Amlodipine Besylate	525	158
Losartan Potassium	Losartan Potassium	451	135
Lisinopril	Lisinopril	256	75
Metoprolol Succinate	Metoprolol Succinate	249	76
Metformin Hcl	Metformin Hcl	239	78
Levothyroxine Sodium	Levothyroxine Sodium	234	70
Tamsulosin Hcl	Tamsulosin Hcl	228	62
Olmesartan Medoxomil	Olmesartan Medoxomil	211	56
Eliquis	Apixaban	202	48
Pantoprazole Sodium	Pantoprazole Sodium	200	53
Jardiance	Empagliflozin	194	48
Famotidine	Famotidine	175	60
Gabapentin	Gabapentin	175	44
Simvastatin	Simvastatin	172	53
Albuterol Sulfate Hfa	Albuterol Sulfate	157	76
Allopurinol	Allopurinol	152	48
Pravastatin Sodium	Pravastatin Sodium	150	45
Furosemide	Furosemide	145	53
Alendronate Sodium	Alendronate Sodium	140	39
Trazodone Hcl	Trazodone Hcl	139	40
Rosuvastatin Calcium	Rosuvastatin Calcium	137	44
Mirtazapine	Mirtazapine	117	34
Metoprolol Tartrate	Metoprolol Tartrate	113	28
Omeprazole	Omeprazole	100	28
Carvedilol	Carvedilol	98	25
Lactulose	Lactulose	93	31
Ozempic	Semaglutide	90	24
Donepezil Hcl	Donepezil Hcl	83	20
Finasteride	Finasteride	79	24
Escitalopram Oxalate	Escitalopram Oxalate	78	21
Quetiapine Fumarate	Quetiapine Fumarate	73	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	71	17
Fluticasone Propionate	Fluticasone Propionate	68	25
Xarelto	Rivaroxaban	67	23
Clopidogrel	Clopidogrel Bisulfate	66	19
Ezetimibe	Ezetimibe	62	21
Montelukast Sodium	Montelukast Sodium	56	16
Triamcinolone Acetonide	Triamcinolone Acetonide	56	36
Bumetanide	Bumetanide	54	13
Spironolactone	Spironolactone	54	16
Tramadol Hcl	Tramadol Hcl	53	24
Metformin Hcl Er	Metformin Hcl	52	17
Prednisone	Prednisone	52	29
Hydrochlorothiazide	Hydrochlorothiazide	48	16
Citalopram Hbr	Citalopram Hydrobromide	47	16
Wixela Inhub	Fluticasone Propion/Salmeterol	47	16
Fluoxetine Hcl	Fluoxetine Hcl	45	19
Hydrocortisone	Hydrocortisone	45	12
Potassium Chloride	Potassium Chloride	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	43	12
Entresto	Sacubitril/Valsartan	42	15
Sertraline Hcl	Sertraline Hcl	40	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	11
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Meclizine Hcl	Meclizine Hcl	36	17
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Ketoconazole	Ketoconazole	34	18
Methimazole	Methimazole	34	suppressed
Clotrimazole	Clotrimazole	33	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	23
Synthroid	Levothyroxine Sodium	33	suppressed
Valsartan	Valsartan	33	11
Chlorthalidone	Chlorthalidone	32	suppressed
Telmisartan	Telmisartan	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Colchicine	Colchicine	31	18
Farxiga	Dapagliflozin Propanediol	31	suppressed
Glipizide	Glipizide	31	suppressed
Irbesartan	Irbesartan	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	16
Atenolol	Atenolol	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Methotrexate	Methotrexate Sodium	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Nystatin	Nystatin	29	15
Ammonium Lactate	Ammonium Lactate	28	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	28	suppressed
Cilostazol	Cilostazol	28	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Mupirocin	Mupirocin	27	18
Propranolol Hcl	Propranolol Hcl	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Lorazepam	Lorazepam	25	11
Oseltamivir Phosphate	Oseltamivir Phosphate	24	24
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Fenofibrate	Fenofibrate,micronized	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	12
Ibuprofen	Ibuprofen	23	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	22	suppressed
Topiramate	Topiramate	22	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	21	suppressed
Estradiol	Estradiol	21	suppressed
Felodipine Er	Felodipine	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	18
Entacapone	Entacapone	18	suppressed
Ursodiol	Ursodiol	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Fluconazole	Fluconazole	15	13
Invokana	Canagliflozin	15	suppressed
Glipizide Er	Glipizide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Clozapine	Clozapine	13	suppressed
Diazepam	Diazepam	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Naproxen	Naproxen	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Azelastine Hcl	Azelastine Hcl	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Cefdinir	Cefdinir	11	11
Cholestyramine Light	Cholestyramine	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ritonavir	Ritonavir	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error